SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as record Super Bowl betting drives immense volume and its Crypto.com partnership expands prediction markets, while the community actively debates whether emerging unregulated prediction platforms pose a significant threat ahead of next week's anticipated earnings.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending following its decision to pull a newly launched compounded weight-loss pill due to regulatory pressure and legal threats. This move has sparked debate, with some viewing it as a significant setback while others believe it strategically removes a legal overhang and positions the core telehealth platform for a rebound, amplified by its Super Bowl ad.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending following a significant Super Bowl commercial featuring Christina Applegate for its Briumvi multiple sclerosis drug, which the community views as a powerful boost for brand visibility and patient confidence. This marketing success, combined with growing discussion over a competitor's drug (Fenebrutinib) and its potential liver toxicity concerns, is intensifying conversation around Briumvi's market leadership and long-term value.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after announcing a $250 million financing amendment, extending its capital runway through 2028, which bulls anticipate will fuel a historic short squeeze given its low float and past parabolic runs. However, community discussion also highlights concerns about potential dilution from the equity line of credit amidst the company's current lack of revenue generation.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

JYAI CRYPTO is trending as community anticipation builds around its confirmed Tier 1 exchange listings and recent debut on platforms like KuCoin Alpha and Bitget. Enthusiasts are actively comparing it to early successful memecoins, fueled by its aggressive 12-week marketing initiative and developer updates.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap (UNI) is trending as its community overwhelmingly supports a game-changing governance proposal to activate a fee switch and implement a significant token burn, aiming to align the protocol's high fee generation with UNI's value and establish deflationary tokenomics.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as strong institutional accumulation and anticipation of a potential Chronoscale spinoff fuel bullish sentiment, with the community highlighting the company's growing contracted revenue pipeline and strategic position to capitalize on massive hyperscaler capital expenditures for AI infrastructure, despite recent market volatility.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is experiencing a strong rally fueled by a resurgence in M&A activity, highlighted by recent acquisitions and numerous buyout rumors as major pharmaceutical companies actively seek to replenish pipelines ahead of patent cliffs. The community is buzzing about a "BioWar" and the sector's perceived undervaluation, with optimism further boosted by positive individual drug developments.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is making strong gains, reaching recent highs following several analyst upgrades and a dividend increase, driven by robust international growth and new value menu initiatives. The community views it as a resilient defensive play, attracting capital amidst broader market uncertainty, despite ongoing debates about menu affordability and pricing for consumers.

Investment Managers Series Trust II - Tradr 2X Long APLD Daily ETF

Tradr 2X Long APLD Daily ETF

APLX is trending due to significant magnified gains from the underlying APLD's strong performance in the AI and data center sectors, with the community actively discussing its "parabolic" moves and potential for quick profits, while also acknowledging the amplified volatility and risks inherent in this 2x leveraged ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider

In the most recent trading session, Humacyte, Inc. (HUMA) closed at $1.02, indicating a +2.24% shift from the previous trading day.

Humacyte, Inc. (NASDAQ:HUMA) Given Average Rating of "Moderate Buy" by Analysts

Shares of Humacyte, Inc. (NASDAQ:HUMA - Get Free Report) have been given an average rating of "Moderate Buy" by the eight ratings firms that are presently covering the stock, Marketbeat.com reports...

Humacyte (NASDAQ:HUMA) Given New $10.00 Price Target at Benchmark

Benchmark cut their target price on Humacyte from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Wednesday...

Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year?

Here is how Humacyte, Inc. (HUMA) and Acrivon Therapeutics, Inc. (ACRV) have performed compared to their sector so far this year.

D. Boral Capital Reiterates "Buy" Rating for Humacyte (NASDAQ:HUMA)

D. Boral Capital reissued a "buy" rating and set a $25.00 price objective on shares of Humacyte in a research report on Monday...

Humacyte, Inc. (NASDAQ:HUMA) Receives Average Recommendation of "Moderate Buy" from Analysts

Humacyte, Inc. (NASDAQ:HUMA - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the firm, MarketBeat Ratings reports. One...

Humacyte's (HUMA) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital reiterated a "buy" rating and issued a $25.00 price target on shares of Humacyte in a research note on Monday...

Humacyte (NASDAQ:HUMA) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered Humacyte from a "hold" rating to a "sell" rating in a research report on Sunday...

Wall Street Zen Upgrades Humacyte (NASDAQ:HUMA) to "Hold"

Wall Street Zen raised Humacyte from a "sell" rating to a "hold" rating in a research report on Saturday...

Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest?

According to the average brokerage recommendation (ABR), one should invest in Humacyte, Inc. (HUMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Humacyte Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

HUMA
Humacyte Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HUMA News

HUMAHumacyte Inc